Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
NCT ID: NCT05496972
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2021-04-21
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
NCT04988009
A Study of a Telemedicine Program for Older Adults With Cancer
NCT04917848
Oncology Associated Symptoms & Individualized Strategies
NCT03122249
Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
NCT05058339
Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities
NCT04990934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To characterize patient and provider satisfaction with telemedicine in RO
Secondary Objective:
* To provide evidence for or against the use of telemedicine in radiation oncology (RO)
* To assess the feasibility of and value added by telemedicine in RO
* To describe barriers and facilitators to telemedicine in RO
* To identify preferred use cases for telemedicine in RO
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemedicine Visits
Participants are asked to fill out a survey about their experience.
Survey Administration
Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey Administration
Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* Access to email and internet to complete the survey
* Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chenyang Wang, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-09908
Identifier Type: OTHER
Identifier Source: secondary_id
2020-1063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.